Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 6Unknown 2Recruiting 2Terminated 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2

Conditions

Motor Activity 34Neoplasms 17Breast Neoplasms 15Carcinoma, Non-Small-Cell Lung 5Polycystic Ovary Syndrome 4Lymphoma 4Sarcopenia 3Prostatic Neoplasms 3Lung Neoplasms 3Fatigue 3Colorectal Neoplasms 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Pain 2Ovarian Neoplasms 2Obesity 2Malnutrition 2Lymphedema 2Insulin Resistance 2Hematologic Neoplasms 2Head and Neck Neoplasms 2Esophageal Neoplasms 2Endometrial Neoplasms 2Colonic Neoplasms 2Cardiovascular Diseases 2Weight Cycling 1Waldenstrom Macroglobulinemia 1Uveal Melanoma 1Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Testicular Neoplasms 1

Interventions

Bevacizumab 41Paclitaxel 35Carboplatin 29pembrolizumab 22Specimen Handling 14Cisplatin 14Cyclophosphamide 13olaparib 12Blood Specimen Collection 11niraparib 10fludarabine 9Magnetic Resonance Spectroscopy 9Drug Therapy 9liposomal doxorubicin 8Topotecan 8Taxes 8Gemcitabine 8Fulvestrant 8Biopsy 8Doxorubicin 6cemiplimab 5abemaciclib 5Surveys and Questionnaires 5Standard of Care 5Injections 5Fluorouracil 5Cytoreduction Surgical Procedures 5trastuzumab deruxtecan 4mirvetuximab soravtansine 4aldesleukin 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Ovarian Neoplasms × Exercise × Clear all
NCT04997096 2026-02-19

Exercise as a Preventive Agent to Combat Immobility in Patients With Ovarian or Endometrial Cancers Receiving Chemotherapy

Dana-Farber Cancer Institute

Phase NA Recruiting
30 enrolled
Gynecologic

Ovarian Neoplasms, Endometrial Neoplasms

NCT05761561 2025-06-03

TEAL

Yale University

Phase NA Recruiting
200 enrolled
Gynecologic

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡